An 68-year-old woman is brought to the emergency department by her daughter due to progressive confusion, agitation, and nausea over the past 24 hours. The daughter notes that the patient has had a mild upper respiratory illness for the last few days and has been taking an over-the-counter remedy frequently. The patient has a medical history of severe osteoarthritis and hypertension. Current home medications include lisinopril and multiple daily doses of an over-the-counter pain reliever.
Temperature is 37.8°C (100.0°F), blood pressure is 110/65 mm Hg, pulse is 114/min, and respirations are 28/min. Pulse oximetry shows 98% on ambient air. Physical examination reveals a diaphoretic, agitated woman who is oriented only to person. She occasionally complains of a "ringing" sound in her ears. The lungs are clear to auscultation bilaterally. Cardiac examination shows tachycardia with a regular rhythm. There is mild, diffuse epigastric tenderness.
Laboratory studies show the following:
Serum chemistry:
Sodium: 140 mEq/L
Potassium: 3.6 mEq/L
Chloride: 104 mEq/L
Bicarbonate: 14 mEq/L
Blood urea nitrogen: 24 mg/dL
Creatinine: 1.3 mg/dL
Glucose: 112 mg/dL
Complete blood count:
Leukocyte count: 14,500/mm³
Arterial blood gas analysis (room air):
pH: 7.42
PaCO2: 21 mm Hg
PaO2: 96 mm Hg
Which of the following is the most appropriate next step in management?
- Intravenous sodium bicarbonateAnswer
- BEndotracheal intubation and mechanical ventilation
- CIntravenous ceftriaxone and azithromycin
- DIntravenous furosemide
- EMeasurement of serum thyroid-stimulating hormone
Answer
The anion gap is elevated: .
For a primary metabolic acidosis with a bicarbonate of mEq/L, Winter's formula predicts respiratory compensation: mm Hg.
Because the patient's actual ( mm Hg) is significantly lower than the expected range ( mm Hg), a concurrent primary respiratory alkalosis is present. This occurs because salicylates directly stimulate the medullary respiratory center.
The cornerstone of management for moderate-to-severe salicylate toxicity is intravenous sodium bicarbonate. This therapy has a dual purpose: 1) Serum alkalinization keeps the weak acid (salicylate) in its ionized, deprotonated state, preventing it from crossing the blood-brain barrier into the central nervous system. 2) Urine alkalinization traps the ionized salicylate in the renal tubules, profoundly enhancing its excretion.